Pages that link to "Q36167137"
Jump to navigation
Jump to search
The following pages link to Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors (Q36167137):
Displaying 50 items.
- Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange (Q24294605) (← links)
- Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing (Q27675773) (← links)
- Chemotherapy Drug Induced Discoordination of Mitochondrial Life Cycle Detected by Cardiolipin Fluctuation (Q28389330) (← links)
- ATR: an essential regulator of genome integrity (Q29547883) (← links)
- Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer (Q30009503) (← links)
- RSK2 Binding Models Delineate Key Features for Activity (Q30432330) (← links)
- Function of a conserved checkpoint recruitment domain in ATRIP proteins (Q33276978) (← links)
- Kinetics of histone H2AX phosphorylation and Chk2 activation in A549 cells treated with topotecan and mitoxantrone in relation to the cell cycle phase (Q33331904) (← links)
- The basic cleft of RPA70N binds multiple checkpoint proteins, including RAD9, to regulate ATR signaling (Q33378038) (← links)
- Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo (Q33574808) (← links)
- The σ2 receptor: a novel protein for the imaging and treatment of cancer (Q33782364) (← links)
- Probing the probes: fitness factors for small molecule tools (Q34001269) (← links)
- Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer (Q34394399) (← links)
- Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators (Q34627739) (← links)
- Xanthones from Mangosteen Extracts as Natural Chemopreventive Agents: Potential Anticancer Drugs (Q34632129) (← links)
- Anaphase catastrophe is a target for cancer therapy (Q34700600) (← links)
- Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [(18)F]ISO-1. (Q35000636) (← links)
- Hedgehog signaling and the retina: insights into the mechanisms controlling the proliferative properties of neural precursors (Q35106144) (← links)
- Integrin beta-8 (ITGB8) silencing reverses gefitinib resistance of human hepatic cancer HepG2/G cell line (Q35482150) (← links)
- Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions (Q35549264) (← links)
- Novel intestinal splice variants of RNA-binding protein CUGBP2: isoform-specific effects on mitotic catastrophe. (Q35731677) (← links)
- Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy (Q35842970) (← links)
- Protein kinases and phosphatases as therapeutic targets in cancer. (Q36463998) (← links)
- Ligand discovery and virtual screening using the program LIDAEUS. (Q36496975) (← links)
- Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA. (Q36562082) (← links)
- Expression of thymidylate synthase in human cells is an early G(1) event regulated by CDK4 and p16INK4A but not E2F. (Q36611467) (← links)
- New combination therapies with cell-cycle agents (Q36737314) (← links)
- Molecular targets and mechanisms of radiosensitization using DNA damage response pathways (Q36792626) (← links)
- Tumor suppressor p16(INK4a) inhibits cancer cell growth by downregulating eEF1A2 through a direct interaction. (Q36918294) (← links)
- The effect of the cyclin-dependent kinase inhibitor flavopiridol on anaplastic large cell lymphoma cells and relationship with NPM-ALK kinase expression and activity (Q37246747) (← links)
- The molecular genetics of breast cancer and targeted therapy (Q37290512) (← links)
- O-desmethylangolensin inhibits the proliferation of human breast cancer MCF-7 cells by inducing apoptosis and promoting cell cycle arrest (Q37325161) (← links)
- Cyclin-dependent kinase inhibitors as potential targeted anticancer agents (Q37407079) (← links)
- Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy (Q37439146) (← links)
- Targeting cell cycle and hormone receptor pathways in cancer. (Q37502364) (← links)
- Measuring and interpreting the selectivity of protein kinase inhibitors (Q37537075) (← links)
- Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin (Q37663479) (← links)
- Molecular pathways for cancer chemoprevention by dietary phytochemicals. (Q37866180) (← links)
- Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate (Q37903704) (← links)
- Cyclin dependent kinases in cancer: potential for therapeutic intervention (Q37987789) (← links)
- DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment. (Q37990061) (← links)
- Cell cycle regulation by the intrinsically disordered proteins p21 and p27. (Q38044415) (← links)
- The oncogene mcts1 (Q38104341) (← links)
- Development of anticancer drugs based on the hallmarks of tumor cells. (Q38182491) (← links)
- Radioprotection of normal tissue cells (Q38196712) (← links)
- DNA damage checkpoint recovery and cancer development (Q38405830) (← links)
- Exploiting replicative stress to treat cancer (Q38466329) (← links)
- Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia (Q38756843) (← links)
- PD-0332991 induces G1 arrest of colorectal carcinoma cells through inhibition of the cyclin-dependent kinase-6 and retinoblastoma protein axis (Q38932951) (← links)
- Co-abrogation of Chk1 and Chk2 by potent oncolytic adenovirus potentiates the antitumor efficacy of cisplatin or irradiation. (Q38992613) (← links)